Literature DB >> 23602186

Docetaxel and permanent alopecia.

Antonella Tosti, Ioulios Palamaras, Mariya Miteva, Cosimo Misciali.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23602186     DOI： 10.1016/j.jaad.2010.06.064

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

2.  Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.

Authors:  Azael Freites-Martinez; Donald Chan; Vincent Sibaud; Jerry Shapiro; Gabriella Fabbrocini; Antonella Tosti; Juhee Cho; Shari Goldfarb; Shanu Modi; Devika Gajria; Larry Norton; Ralf Paus; Tessa Cigler; Mario E Lacouture
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

3.  Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question.

Authors:  Alfredo Rebora; Marcella Guarrera
Journal:  Skin Appendage Disord       Date:  2021-05-06

4.  CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia.

Authors:  Talveen S Purba; Kayumba Ng'andu; Lars Brunken; Eleanor Smart; Ellen Mitchell; Nashat Hassan; Aaron O'Brien; Charlotte Mellor; Jennifer Jackson; Asim Shahmalak; Ralf Paus
Journal:  EMBO Mol Med       Date:  2019-09-12       Impact factor: 12.137
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.